D. Mark Anderson

3.6k total citations
84 papers, 1.8k citations indexed

About

D. Mark Anderson is a scholar working on Pulmonary and Respiratory Medicine, Sociology and Political Science and General Health Professions. According to data from OpenAlex, D. Mark Anderson has authored 84 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Sociology and Political Science and 15 papers in General Health Professions. Recurrent topics in D. Mark Anderson's work include Cannabis and Cannabinoid Research (14 papers), Substance Abuse Treatment and Outcomes (14 papers) and Crime Patterns and Interventions (11 papers). D. Mark Anderson is often cited by papers focused on Cannabis and Cannabinoid Research (14 papers), Substance Abuse Treatment and Outcomes (14 papers) and Crime Patterns and Interventions (11 papers). D. Mark Anderson collaborates with scholars based in United States, Spain and Germany. D. Mark Anderson's co-authors include Daniel I. Rees, Benjamin Hansen, Joseph J. Sabia, Kerwin Kofi Charles, Erdal Tekin, Mary Beth Walker, Benjamin Crost, Kimberly Rennie, Joseph P. Neglia and Leslie Robison and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

D. Mark Anderson

79 papers receiving 1.7k citations

Peers

Countries citing papers authored by D. Mark Anderson

Since Specialization

Citations

This map shows the geographic impact of D. Mark Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Mark Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Mark Anderson more than expected).

Fields of papers citing papers by D. Mark Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Mark Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Mark Anderson. The network helps show where D. Mark Anderson may publish in the future.

Co-authorship network of co-authors of D. Mark Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of D. Mark Anderson. A scholar is included among the top collaborators of D. Mark Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Mark Anderson. D. Mark Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world effectiveness of palbociclib plus endocrine therapy in HR+/HER2− advanced breast cancer: final results from the POLARIS trial 2024 ·The Oncologist ·Debu Tripathy, Joanne L. Blum, Meghan Karuturi, Steven McCune, Sobha Kurian, Mehdi M. Moezi, D. Mark Anderson, Eric Gauthier, Zhe Zhang, (unknown), Yao Wang, Gabrielle B. Rocque	2
2	The effects of becoming a physician on prescription drug use and mental health treatment 2023 ·Journal of Health Economics ·D. Mark Anderson, Ron Diris, Raymond Montizaan, Daniel I. Rees	1
3	Identifying key dimensions of indigenous led child welfare services: A qualitative literature review 2023 ·Child & Family Social Work ·(unknown), Paula Toko King, L. J. Lewis, Shayne Walker, (unknown), D. Mark Anderson, (unknown), Susan P. Kemp	3
4	373P Impact of comorbidities on real-world (rw) clinical outcomes of patients (pts) with hormone receptor-positive/human epidermal growth factor 2-negative (HR+/HER2-) advanced breast cancer (ABC) treated with palbociclib and enrolled in POLARIS 2023 ·Annals of Oncology ·Debu Tripathy, Joanne L. Blum, Meghan Karuturi, Steve McCune, (unknown), (unknown), D. Mark Anderson, (unknown), (unknown), Zhe Zhang, Eric Gauthier, Gabrielle B. Rocque	3
5	Ka mua, ka muri—Walking backwards into the future 2023 ·Aotearoa New Zealand Social Work ·L. J. Lewis, Shayne Walker, Paula Toko King, (unknown), (unknown), D. Mark Anderson, Susan P. Kemp	1
6	Organizational Characteristics and Smoking Cessation Support in Community-Based Lung Cancer Screening Programs 2022 ·Journal of the American College of Radiology ·Christina Bellinger, Kristie L. Foley, Emily V. Dressler, Carol Kittel, David P. Miller, Kathryn E. Weaver, Erin L. Sutfin, W. Jeffrey Petty, John G. Spangler, (unknown), D. Mark Anderson, (unknown), (unknown), Rajiv Panikkar, Caroline Chiles	5
7	Child access prevention laws and juvenile firearm-related homicides 2021 ·Journal of Urban Economics ·D. Mark Anderson, Joseph J. Sabia, Erdal Tekin	8
8	LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer 2020 ·Annals of Oncology ·Erica L. Mayer, (unknown), Angela DeMichele, Miguel Martín, Harold J. Burstein, Aleix Prat, Gábor Rubovszky, Kathy D. Miller, Georg Pfeiler, Eric P. Winer, Nicholas Zdenkowski, D. Mark Anderson, Zbigniew Nowecki, Sibylle Loibl, Hannes Fohler, Otto Metzger, Debora Fumagalli, Kathy Puyana Theall, Christian Fesl, Amylou C. Dueck	23
9	The phenomenon of summer diarrhea and its waning, 1910-1930 2020 ·Explorations in Economic History ·D. Mark Anderson, Daniel I. Rees, Tianyi Wang	11
10	CIGARETTE TAXES AND TEEN MARIJUANA USE 2020 ·National Tax Journal ·D. Mark Anderson, Kyutaro Matsuzawa, Joseph J. Sabia	16
11	Intracerebral hemorrhage after IV tPA for stroke as early symptom of ANCA-associated vasculitis 2017 ·eNeurologicalSci ·(unknown), D. Mark Anderson, (unknown), Harold P. Adams	7
12	Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial 2016 ·Annals of Oncology ·Harry H. Yoon, Johanna C. Bendell, Fadi S. Braiteh, Irfan Firdaus, P. A. Philip, Allen Lee Cohn, Nancy Lewis, D. Mark Anderson, Edward Arrowsmith, Jonathan D. Schwartz, Ling Gao, Yanzhi Hsu, Yiwen Xu, D. Ferry, Steven R. Alberts, Zev A. Wainberg	98
13	The effect of parental involvement laws on teen birth control use 2015 ·Journal of Health Economics ·Joseph J. Sabia, D. Mark Anderson	25
14	NCCTG N0821 (Alliance): A Phase II First-Line Study of Pemetrexed, Carboplatin, and Bevacizumab in Elderly Patients with Advanced Nonsquamous Non–Small-Cell Lung Cancer With Good Performance Status 2014 ·Journal of Thoracic Oncology ·Grace K. Dy, Julian R. Molina, Yingwei Qi, Rafat Ansari, Sachdev Thomas, Helen J. Ross, Gamini S. Soori, D. Mark Anderson, Marie Christine Aubry, Jeffrey P. Meyers, Araba A. Adjei, Sumithra J. Mandrekar, Alex A. Adjei	6
15	High School Dropouts and Sexually Transmitted Infections 2013 ·Southern Economic Journal ·D. Mark Anderson, Claus C. Pörtner	13
16	The Alignment of the easyCBM Middle School Mathematics CCSS Measures to the Common Core State Standards. Technical Report #1208. 2012 ·D. Mark Anderson, (unknown), Julie Alonzo, Gerald Tindal	2
17	Technical Adequacy of the easyCBM Reading Measures (Grades 3-7), 2009-2010 Version. Technical Report #1005. 2010 ·Leilani Sáez, (unknown), Joseph F. T. Nese, (unknown), (unknown), D. Mark Anderson, Akihito Kamata, Julie Alonzo, Gerald Tindal	5
18	Does information matter? The effect of the Meth Project on meth use among youths 2010 ·Journal of Health Economics ·D. Mark Anderson	55
19	A model for wetting and evaporation of a post-blink precorneal tear film 2009 ·Bulletin of the American Physical Society ·D. Mark Anderson, (unknown), Richard Braun	0
20	Medical and neurocognitive late effects among survivors of childhood central nervous system tumors 2001 ·Cancer ·D. Mark Anderson, Kimberly Rennie, Richard Ziegler, Joseph P. Neglia, Leslie Robison, James G. Gurney	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact